Atamestane

DB12194InvestigationalSmall molecule

Atamestane has been used in trials studying the treatment of Breast Cancer, Breast Neoplasms, and Neoplasms, Hormone-Dependent.

Chemical structure of Atamestane
Mechanism
Curator reviewed
Formula / weight
C20H26O2 · 298.426 g/mol (avg)
Code names
SH-489

Resolves to

Compound
UNII62GA3K28B6CAS96301-34-7ChEMBLCHEMBL2105987PubChem57050
Structure
InChIKeyPEPMWUSGRKINHX-TXTPUJOMSA-NSMILESCC1=CC(=O)C=C2CC[C@H]3[C@@H]4CCC(=O)[C@@]4(C)CC[C@@H]3[C@@]12C
Targets
P11511CYP19A1

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
62Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Atamestane, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In